Patients Self-Medicating Is Driving The Growth Of The Cannabis Market

Cannabis cultivation, research, distribution and use is a hot button issue in the United States today. It is being driven by the major changes in laws governing the plant. Many jurisdictions have voted to legalize or decriminalize cannabis possession and use and this has led to an unprecedented growth in the cannabis market. The increasing acknowledgement of the efficacy of medical use of cannabis has led to much of the change in the way the herb is viewed. In 25 states as well as the District of Columbia individuals are no longer prosecuted for medical marijuana possession or sale. In a growing number of community’s recreational use of cannabis is legal.

A major part of reason for the growth in the cannabis market is because people are using it to treat the nausea and vomiting caused by chemotherapy. HIV/AIDSS patients are using it to improve their appetites. People with chronic pain caused by neuropathy, fibromyalgia and rheumatoid arthritis are finding relief when they use cannabis. Plus it helps people with muscle spasms, improves sleep and lessens the severity of tics in people with Tourette syndrome. Cannabis can also be used to treat anorexia, arthritis, glaucoma, migraine and neurological problems like multiple sclerosis, movement problems and epilepsy as well as posttraumatic stress disorder.

The American Academy of Pediatrics, the Minnesota Medical Association and the American Medical Association have all called for more research on cannabis as a treatment for a wide variety of ailments. Research has found that much of the cannabis market growth is caused by people with medical issues self-medicating using the herb. Medical professional want more information on the effectiveness of cannabis in treating a wide range of medical conditions. Some conditions cannabis shows promise in treating include cancer cell growth, dementia, Alzheimer’s disease, anxiety, depression, psychosis, diabetes, epilepsy, glaucoma, Huntington’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, bipolar disorder, anorexia nervosa, digestive diseases, brain diseases and inflammatory bowel disease.

The cannabis markets are filled with patients that have experimented with cannabis on their own and found it has valuable analgesic and anti-inflammatory effects. Many of them use it to treat inflammation, cough, congestion and convulsions. There are a number of excellent methods for administering medical cannabis to give patients the relief they need. They include using liquid tinctures, smoking or vaporizing dried buds, taking capsules or lozenges, eating cannabis edibles, using dermal patches or trying oral or dermal sprays. Both patients and medical professionals are aware of these methods.

With cannabis having the potential to treat so many illnesses and ailments it’s not surprising that there has been significant growth in the cannabis markets. Not only are patients using it on their own or under the supervision of medical personnel, a number of pharmaceutical companies are also doing research on cannabis. So far they have produced cannabis in pills, sprays and patches. They have also created synthetic forms of the active ingredients in the plant. All of these efforts have helped the cannabis markets to grow. However, for many patients using the plant is the most effective way to get the cannabis they need.

In the United States cannabis has a Schedule I classification. Medical researchers are clamoring for a change of this classification to do more cannabis-related research. Currently the power to change the classification of cannabis is in the hands of the Food and Drug Administration, the Drug Enforcement Administration and the National Institute on Drug Abuse. With their approval patients can get legal cannabis and eliminate the illegal cannabis markets. Patients could simply view website content guiding them to legal sources of cannabis.